Clinical Trial ProgressThe data safety monitoring board has completed its safety review of the intravenous dosing rates with determination to continue without modification.
Innovation And Treatment PotentialDM199 has the potential as a disease-modifying therapy for facilitating placental perfusion, reducing blood pressure, and improving endothelial function.
Market Position And Acquisition PotentialPositive preeclampsia results could solidify the company as a likely takeout candidate, potentially catalyzed by positive stroke data.